Stifel: Buy Vetrex, Checks Predict Strong Orkambi Launch

By: via Benzinga
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) are up 9 percent year-to-date, but slipped below the $100 mark in ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.